| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |